You just read:

Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

News provided by

Gracell

Jun 20, 2019, 08:00 ET